Please provide your email address to receive an email when new articles are posted on . Corticosteroid use during pregnancy was not linked with developmental milestone delays. Beta-2 adrenergic ...
Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...
a FDA = Food and Drug Administration, COPD = chronic obstructive pulmonary disease. b p represents the level of significance for the comparison between patients who filled an initial prescription for ...
A team from Atrogi AB has reported the activity of ATR-127, a novel dual adrenergic agonist targeting β2- and β3-adrenoceptors (ARs), for the potential treatment of steatohepatitis, obesity and ...
Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and ...
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...
The FDA has approved phentolamine ophthalmic solution (Ryzumvi) 0.75% for treatment-induced mydriasis, Viatris and Ocuphire Pharma announced. The approval stipulates use of the eye drops to manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results